ABSTRACT
Phosphorylated insulin-like growth factor binding protein-1 (phIGFBP-1) is secreted by decidual cells and may leak into cervical secretions during detachment of the fetal membrane. The aim of this study was to determine whether a rapid bedside test for phIGFBP-1 predicts preterm birth in women with preterm uterine contractions. This was a prospective study of pregnant women who sought medical care for symptoms of preterm labor. Cervical swabs were assayed for the presence of phIGFBP-1 by a rapid bedside test. Sixty-four patients were enrolled. Eleven of them (17%) delivered preterm (< 35 weeks). phIGFBP-1 in cervical secretions predicted preterm birth with a sensitivity of 72.7%, a specificity of 83.0%, a positive predictive value of 47.0%, and negative predictive value of 93.6%. Positive phIGFBP-1 bedside test in women with preterm uterine contractions may indicate a significant risk for subsequent preterm birth. The absence of phIGBP-1 is a reassuring sign that the likelihood of preterm birth is low.
KEYWORDS
phIGFBP-1 - preterm delivery
REFERENCES
-
1
Copper R L, Goldenberg R L, Creasy R K et al..
A multicenter study of preterm birth weight and gestational age-specific neonatal mortality.
Am J Obstet Gynecol.
1993;
168
78-84
-
2
Papiernik E, Bouyer J, Collin D, Winisdoerffer G, Dreyfus J.
Precocious cervical ripening and preterm labor.
Obstet Gynecol.
1986;
67
238-242
-
3
Iams J D, Goldenberg R L, Meis P J et al..
The length of the cervix and the risk of spontaneous premature delivery. National Institute of Child Health and Human Development Maternal Fetal Medicine Unit Network.
N Engl J Med.
1996;
334
567-572
-
4
Lockwood C J, Senyei A E, Dische M R et al..
Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery.
N Engl J Med.
1991;
325
669-674
-
5
Rutanen E M, Bohn H, Seppala M.
Radioimmunoassay of placental protein 12: levels in amniotic fluid, cord blood, and serum of healthy adults, pregnant women, and patients with trophoblastic disease.
Am J Obstet Gynecol.
1982;
144
460-463
-
6
Frost R A, Tseng L.
Insulin-like growth factor-binding protein-1 is phosphorylated by cultured human endometrial stromal cells and multiple protein kinases in vitro.
J Biol Chem.
1991;
266
18082-18088
-
7
Koistinen R, Angervo M, Leinonen P, Hakala T, Seppala M.
Phosphorylation of insulin-like growth factor-binding protein-1 increases in human amniotic fluid and decidua from early to late pregnancy.
Clin Chim Acta.
1993;
215
189-199
-
8
Rutanen E M, Karkkainen T, Lundqvist C et al..
Monoclonal antibodies to the 27-34K insulin-like growth factor binding protein.
Biochem Biophys Res Commun.
1988;
152
208-215
-
9
Nuutila M, Hiilesmaa V, Karkkainen T, Ylikorkala O, Rutanen E M.
Phosphorylated isoforms of insulin-like growth factor binding protein-1 in the cervix as a predictor of cervical ripeness.
Obstet Gynecol.
1999;
94
243-249
-
10
Kekki M, Kurki T, Karkkainen T, Hiilesmaa V, Paavonen J, Rutanen E M.
Insulin-like growth factor-binding protein-1 in cervical secretion as a predictor of preterm delivery.
Acta Obstet Gynecol Scand.
2001;
80
546-551
-
11
Lembet A, Eroglu D, Ergin T et al..
New rapid bed-side test to predict preterm delivery: phosphorylated insulin-like growth factor binding protein-1 in cervical secretions.
Acta Obstet Gynecol Scand.
2002;
81
706-712
-
12
Rutanen E M, Karkkainen T H, Lehtovirta J, Uotila J T, Hinkula M K, Hartikainen A L.
Evaluation of a rapid strip test for insulin-like growth factor binding protein-1 in the diagnosis of ruptured fetal membranes.
Clin Chim Acta.
1996;
253
91-101
-
13
Nageotte M P, Casal D, Senyei A E.
Fetal fibronectin in patients at increased risk for premature birth.
Am J Obstet Gynecol.
1994;
170
20-25
-
14
Cherouny P H, Pankuch G A, Romero R et al..
Neutrophil attractant/activating peptide-1/interleukin-8: association with histologic chorioamnionitis, preterm delivery, and bioactive amniotic fluid leukoattractants.
Am J Obstet Gynecol.
1993;
169
1299-1303
-
15
Inglis S R, Jeremias J, Kuno K et al..
Detection of tumor necrosis factor-alpha, interleukin-6, and fetal fibronectin in the lower genital tract during pregnancy: relation to outcome.
Am J Obstet Gynecol.
1994;
171
5-10
-
16
Ascarelli M H, Morrison J C.
Use of fetal fibronectin in clinical practice.
Obstet Gynecol Surv.
1997;
52
S1-12
-
17
Hill W C.
A guest editorial: where are we now in screening patients for preterm delivery?.
Obstet Gynecol Surv.
2002;
57
133-135
-
18
Rutanen E M, Pekonen F, Karkkainen T.
Measurement of insulin-like growth factor binding protein-1 in cervical/vaginal secretions: comparison with the ROM-check Membrane Immunoassay in the diagnosis of ruptured fetal membranes.
Clin Chim Acta.
1993;
214
73-81
Shai E ElizurM.D.
Department of Obstetrics and Gynecology, The Chaim Sheba Medical Center
Tel-Hashomer, 52621, Israel